ArunA Biomedical Inc, based in Athens, GA, is a pioneering company that has developed a proprietary neural exosome platform, enabling access across the blood-brain barrier. Their therapeutic neural cell-derived exosome, AB126, showcases multiple modes of action, including reducing neuro-inflammation, promoting neuro-protection, and stimulating neuro-regeneration. With its potential to treat acute neuro-conditions and chronic neurodegenerative diseases, ArunA Bio's groundbreaking technology holds the promise of transforming the lives of millions worldwide.
Unlocking new possibilities for individuals with neurological diseases, ArunA Biomedical Inc has harnessed their own neural exosome platform, AB126, to overcome the blood-brain barrier. This therapeutic neural cell-derived exosome exhibits a range of beneficial effects, such as reducing neuro-inflammation, promoting neuro-protection, and stimulating neuro-regeneration. By targeting acute neuro-conditions and chronic neurodegenerative diseases, ArunA Bio's innovative approach has the potential to revolutionize the lives of millions globally.
Generated from the website